APA (7th ed.) Citation

Eckardt, J., Stasik, S., Kramer, M., Röllig, C., Krämer, A., Scholl, S., . . . Middeke, J. M. (2021). Loss-of-function mutations of BCOR are an independent marker of adverse outcomes in intensively treated patients with acute myeloid leukemia. Cancers, 13(9), . https://doi.org/10.3390/cancers13092095

Chicago Style (17th ed.) Citation

Eckardt, Jan-Niklas, et al. "Loss-of-function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia." Cancers 13, no. 9 (2021). https://doi.org/10.3390/cancers13092095.

MLA (9th ed.) Citation

Eckardt, Jan-Niklas, et al. "Loss-of-function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia." Cancers, vol. 13, no. 9, 2021, https://doi.org/10.3390/cancers13092095.